2017 News

HarborPath Celebrates Fifth Anniversary in Providing Access to HIV/AIDS and hepatitis C Medications to Eligible Uninsured Patients

 

Charlotte, NC - July 10, 2017 - HarborPath, a non-profit organization, was established in 2012 in response to the urgent need to bridge medication options for HIV/AIDS patients. Today, the organization continues to receive recognition as a national leader in patient services and free product distribution for eligible uninsured HIV/AIDS and hepatitis C patients. A growing need remains for patient access to free medications as a result of insurance gaps, changes to the healthcare system, Affordable Care Act, and product delays due to AIDS Drug Assistance Programs (ADAPs), Medicaid, Medicare part D and Healthcare Exchanges Plan policies.

 

The HarborPath program addresses a critical need and offers an important safety net while shedding more light on the impact of the HIV and hepatitis C epidemics have on patients, their families, and communities. Dr. Donna Sweet, HarborPath Chair notes, "HarborPath was envisioned after discussions and requests from the community and industry for a streamlined and collaborative solution to serve more patients in need. Our program is simplifying access for thousands of individuals living with HIV/AIDS and hepatitis C. Without HarborPath, more patients would fall out of the healthcare system and health outcomes would be diminished."

 

The Goal of HarborPath is to expand access and improve outcomes for underserved patient populations living with HIV/AIDS and hepatitis C. This important mission is achieved through:

 

  • Generous support from health philanthropies and pharmaceutical manufacturers that share a common goal to help underserved patients access lifesaving medications

  • Dedication and support from patient advocates who are passionate about helping patients start and stay on their prescribed medications

  • A comprehensive website with an easy-to-use 'single' portal to determine needs based status, and in some cases, pre-existing public program eligibility

  • An accredited pharmacy with a national reach that ships product in one package within 48 hours of application approval

 

HarborPath is one of many support offerings for HIV/AIDS and hepatitis C patients. Based on a recent provider/Patient Advocate satisfaction survey, 92 percent of providers and patient advocates polled were very satisfied with services from HarborPath. Susanna Naggie, MD, MHS, Associate Professor of Medicine at Duke University Medical Center said, "Given the growing number of patients in need, there continues to be overwhelming support for HarborPath, and there is a compelling case for this valued resource to exist long into the future."

 

HarborPath continues to receive strong support from the HIV community including:

 

  • National Alliance of state territorial AIDS Directors

  • State ADAP Offices

  • Fair Pricing Coalition

  • Providers, Patient Advocates, Pharmacies

  • Academic Medical Centers

  • Pharmaceutical Companies

  • Diagnostic Centers

 

The HarobPath survey also revealed that more than 50 percent of HIV/AIDS patients are on combination therapies. HarborPath is the only option available today that offers a single enrollment form and ensures medications can get to these patients in a single shipment. This is especially helpful to patients living in rural areas who are burdened by transportation and financial obstacles.

 

Brenda Johnston, Patient Advocate from Tarrant County Public Health in Fort Worth, TX commented, "We appreciate HarborPath. The patients we serve benefit from this program and health outcomes are improved with help from harborPath's dedicated support staff, a simplified eligibility and enrollment process and convenient shipping alternatives."

 

Pharmaceutical companies supporting HarborPath include AbbVie, Gilead, Johnson & Johnson Patient Assistance Foundation, Merck and ViiV Healthcare. In addition, Quest Diagnostics provides Resistance Testing for uninsured patients who qualify for the hepatitis C genotype testing. Without the generous and ever growing support from these organization, HarborPath could not achieve its important mission to expand access and improve outcomes

 

About HarborPath:

 

HarborPath is a 501 (c) (3) non-profit organization dedicated to assisting low-income, uninsured people living with HIV/AIDS, hepatitis C and other complex chronic conditions gain access to their entire regimen of brand-name prescription medications through a single portal. For more information, visit www.harborpath.org

 

Media Contacts:

Ken Trogdon, Jr.

President

HarborPath

980-859-3483

 

 

 

 

HarborPath
 

Woodfield Corporate Center
8000 Corporate Center Drive Suite 200

Charlotte, NC 28226

Tel: 980-859-3483

Fax: 980-938-5393

© 2018 HarborPath, Inc. All rights reserved.